Trial analysis by treatment allocated or by treatment received? Origins of ‘the intention-to-treat principle’ to reduce allocation bias: Part 2

Bird SM. The 1959 meeting in Vienna on controlled clinical trials – a methodological landmark. JLL Bulletin: Commentaries on the history of treatment evaluation. 2014. See www.jameslindlibrary.org/articles/the-1959-meeting-in-vienna-on-controlled-clinical-trials-a-methodological-landmark/ (last checked 4 October 2023).

Hill AB. Controlled Clinical Trials. Oxford: Blackwell Scientific Publications, 1960.

Schwartz D Flamant R Lellouch J Rouquette C. Les essais thérapeutiques cliniques. Paris: Masson, 1960.

Armitage P. The construction of comparable groups. In: Hill AB , ed. Controlled Clinical Trials. Oxford: Blackwell, 1960: 14–18.

Bywaters E. Rheumatoid arthritis. Treatment and illustrative answers. In: Hill AB , ed. Controlled Clinical Trials. Oxford: Blackwell, 1960: 75–83.

Paterson R. Clinical trials in malignant disease. In: Hill AB , ed. Controlled Clinical Trials. Oxford: Blackwell Scientific Publications, 1960: 125–133.

Knowelden J. The analysis and presentation of results. In: Hill AB , ed. Controlled Clinical Trials. Oxford: Blackwell Scientific Publications, 1960: 155–159.

Hill AB. Principles of Medical Statistics. 6th edition. Oxford: Blackwell Scientific Publications, 1955.

Hill AB. Principles of Medical Statistics. 7th edition. Oxford: Oxford University Press, 1961: 258–259.

Hill AB. Alfred Watson Memorial Lecture: the statistician in medicine. J Inst Actuaries 1962; 88: 178–191.

Hill AB Hill ID. Differential exclusions. In: Bradford Hill’s Principles of Medical Statistics. 12th edition. London: Edward Arnold, 1991:226–228.

Newell DJ. Intention-to-Treat analysis: implications for quantitative and qualitative research. Int J Epidemiol 1992; 21: 837–841.

Fergusson D Aaron SD Guyatt G Hébert P. Post-randomization exclusions: the intention to treat principle and excluding patients from analysis. BMJ 2002; 325: 652–654.

Fisher LD Dixon DO Herson J Frankowski RK Hearon MS Peace KE. Intention to Treat in clinical trials. In: Peace KE , ed. Statistical Issues in Drug development. New York: Marcel Dekker, 1990: 331–350.

Gupta SK. Intention to treat concept: a review. Perspect Clin Res 2011; 2: 109–112.

Hollis S Campbell F. What is meant by intention-to-treat analysis? Survey of published randomised controlled trials. BMJ 1999; 319: 670–674.

International Conference on Harmonisation. Statistical principles for clinical trials (ICH E9). Statistics in Medicine 1999; 18: 1905–1942.

Lee YJ Ellenberg JH Hirtz DFG Nelson KB. Analysis of clinical trial by treatment actually received: is it really an option? Stat Med 1991; 10: 1595–1605.

McCoy CE. Understanding the intention-to-treat principle in randomized controlled trials. West J Emerg Med 2017; 18: 1075–1078.

Montori VM Guyatt GH. Intention-to-treat principle. CMAJ 2001; 165: 1339–1341.

Wiens BL Zhao W. The role of intention to treat in analysis of noninferiority trials. Clin Trials 2007; 2: 286–291.

White IR Carpenter J Horton NJ. Including all individuals is not enough: lessons for intention-to-treat analysis. Clin Trials 2012; 9: 396–407.

Sheiner LB Rubin DB. Intention‐to‐treat analysis and the goals of clinical trials. Clin Pharmacol Therap 1995; 57: 6–15.

Feinman RD. Intention to treat. What is the question? Nutr Metab 2009; 6: 1.

Schwartz D. L’expérimentation en thérapeutique. J de la Société Statistique de Paris 1961; 102: 16–25.

Schwartz D Flamant R Lellouch J. L’essai thérapeutique chez l’homme. Paris: Flammarion, 1970.

Armitage P. Attitudes in clinical trials. Stat Med 1998; 17: 2675–2683.

Ruiz-Canela M Martinez-Gonzalez MA de Irala-Estevez J. Intention-to-treat analysis is related to methodological quality. BMJ 2000; 320: 107–108.

Furberg CD. How should one analyse and interpret clinical trials in which patients don’t take the treatments assigned to them? JLL Bulletin: Commentaries on the history of treatment evaluation. 2009. See www.jameslindlibrary.org/articles/how-should-one-analyse-and-interpret-clinical-trials-in-which-patients-dont-take-the-treatments-assigned-to-them/ (last checked 4 October 2023).

Abraha I Montedori A. Modified Intention to Treat reporting in randomised controlled trials: systematic review. BMJ 2010; 340: c2697.

Montedori A Cherubini A Bonacini MI Casazza G Luchetta ML Duca P , et al. Modified versus standard intention-to-treat reporting: are there differences in methodological quality, sponsorship, and findings in randomised trials? A cross-sectional study. Trials 2011; 12: 58.

Abraha I Cherubini A Cozzolino F De Florio R Luchetta ML Rimland JM , et al. Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study. BMJ 2015; 350: h2445.

International Conference on Harmonisation. ICH E9 (R1): Addendum on estimands and defining sensitivity analyses to the Guideline on Statistical Principles for Clinical Trials (ICH E9). Statistics in Medicine 2019; 18: 1905–1942.

Newcombe RG. Explanatory and pragmatic estimates of the treatment effect when deviations from allocated treatment occur. Stat Med 1988; 7: 1179–1186.